216 related articles for article (PubMed ID: 9391182)
21. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
Rumsey WL; Rosenspire KC; Nunn AD
J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
[TBL] [Abstract][Full Text] [Related]
22. Reliability of technetium-99m Q12 and thallium-201 myocardial activity measurements after triphenyl tetrazolium chloride myocardial staining by perfusion.
Lenihan DJ; McGoron AJ; Gabel M; Walsh RA; Gerson MC
Invest Radiol; 1999 Apr; 34(4):276-81. PubMed ID: 10196719
[TBL] [Abstract][Full Text] [Related]
23. [A comparison between 99mTc-Q3 and 201Tl on clearance and retention properties at varying coronary flow rates in isolated rabbit heart].
Fan C; Tan T; Li Y; Kuang A; Liang Z; Chen Y
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):225-8, 231. PubMed ID: 12600092
[TBL] [Abstract][Full Text] [Related]
24. Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ32014) and thallium.
Leppo JA; Meerdink DJ
J Nucl Med; 1990 Jan; 31(1):67-74. PubMed ID: 2295943
[TBL] [Abstract][Full Text] [Related]
25. Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium.
Melon PG; Beanlands RS; DeGrado TR; Nguyen N; Petry NA; Schwaiger M
J Am Coll Cardiol; 1992 Nov; 20(5):1277-83. PubMed ID: 1401632
[TBL] [Abstract][Full Text] [Related]
26. Myocardial uptake of technetium-99m-furifosmin (Q12) versus technetium-99m-sestamibi (MIBI).
Bangard M; Bender H; Grünwald F; Hümmelgen M; Willkomm P; Palmedo H; Lüderitz B; Biersack HJ
Nuklearmedizin; 1999; 38(6):189-91. PubMed ID: 10510802
[TBL] [Abstract][Full Text] [Related]
27. Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201.
Takahashi N; Dahlberg ST; Gilmore MP; Leppo JA
J Nucl Cardiol; 1997; 4(6):524-31. PubMed ID: 9456193
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the overall first-pass kinetics of thallium-201 and technetium-99m MIBI in normoxic and low-flow ischaemic myocardium.
Ayalew A; Marie PY; Menu P; Mertes PM; Hassan N; Danchin N; Olivier P; Karcher G; Bertrand A
Eur J Nucl Med; 2000 Nov; 27(11):1632-40. PubMed ID: 11105819
[TBL] [Abstract][Full Text] [Related]
29. Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart.
Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
Circulation; 1990 Sep; 82(3):998-1007. PubMed ID: 2394016
[TBL] [Abstract][Full Text] [Related]
30. The effect of flow on technetium-99m-teboroxime (SQ30217) and thallium-201 extraction and retention in rabbit heart.
Marshall RC; Leidholdt EM; Zhang DY; Barnett CA
J Nucl Med; 1991 Oct; 32(10):1979-88. PubMed ID: 1919742
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.
Nakamura K; Sammiya T; Hashimoto J; Ishibashi R; Matsumoto K; Kubo A
Ann Nucl Med; 1996 Nov; 10(4):375-81. PubMed ID: 9006721
[TBL] [Abstract][Full Text] [Related]
32. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
Caner B; Beller GA
Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
[TBL] [Abstract][Full Text] [Related]
33. Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart.
Fukushima K; Momose M; Kondo C; Kusakabe K; Kasanuki H
Ann Nucl Med; 2007 Jul; 21(5):267-73. PubMed ID: 17634844
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi.
Marshall RC; Powers-Risius P; Reutter BW; Taylor SE; VanBrocklin HF; Huesman RH; Budinger TF
J Nucl Med; 2001 Feb; 42(2):272-81. PubMed ID: 11216526
[TBL] [Abstract][Full Text] [Related]
35. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.
Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A
J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240
[TBL] [Abstract][Full Text] [Related]
36. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
Weinstein H; Reinhardt CP; Leppo JA
J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
39. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H
Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130
[TBL] [Abstract][Full Text] [Related]
40. Kinetic analysis of 99mTc-sestamibi evaluates the protective effects by ischaemic preconditioning on ischaemic myocardium in an isolated rabbit heart.
Liang J; Chen HL; Zhou Y; Xie M; Xu LM; Lin G
Nucl Med Commun; 2007 Nov; 28(11):864-9. PubMed ID: 17901770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
